Schedule for the remainder of Spring 2017 schedule
March 24 intent to treat vs per protocol; regulatory; corporate governance
March 31 reporting and auditing; IP and patents
April 7 business development and negotiation
April 14 case study
April 21 case study
April 28 review and good and welfare
May 5 final exam (tentative date)
March 31 reporting and auditing; IP and patents
April 7 business development and negotiation
April 14 case study
April 21 case study
April 28 review and good and welfare
May 5 final exam (tentative date)
Topic list for final exam (if we have one)
- size of world economy
- Compare Exxon or Walmart’s revenue vs biotech industry revenue
- Company metrics of biotech industry
- Profitability of the biotech industry
- Funding cycle in biotech and elsewhere
- Business forms: sole proprietorship, partnership, PC, LLC and corporations
- Income pass-throughs and limits of liability
- Basics of accounting entries: debit and credits
- Asset accounting: depreciation, accounting for land, amortization of goodwill
- Construction of and theory behind the accounting statements
- What determines a public company’s ability to raise money
- The elevator pitch
- The business plan
- Business communication
- Sources of funding for biotech
- Biotech labor metrics
- Parallel tracks in early business formation
- Pricing models for competitive, monopoly and non-price competition industries
- Patents
- Definition of economic rent and how it applies to pricing
- Definition of commodity and how it applies to pricing
- Bootstrapping: definition
- Valuing an equity stake
- Equity vs debt
- Capital structure: definition and what makes a good capital structure
- Disposition of assets after bankruptcy
- Rationale behind accelerating or deferring recognition of expenses
- Clinical development: types of information expected in a phase 1 trial
- Purpose of phase 2 testing
- Why phase three trials fail
- Common statistical mistakes in clinical trial design
- Differences between per protocol and intent to treat analyses
- What auditors do
- Function and tasks of a board of directors
- Calculation and strategic importance of gross margin
- Patent costs and timing
- How to screw up a patent strategy
- What makes a good (or bad) clinical trial endpoint
- Differences between entrepreneurship in biotech and other industries
- How FDA regulates the marketing of a drug
- Negotiating a business development agreement in biotech